apricus wealth LLC Sells 28,475 Shares of Unum Group (NYSE:UNM)

apricus wealth LLC lessened its stake in shares of Unum Group (NYSE:UNM - Free Report) by 44.6% in the first quarter, according to its most recent filing with the SEC. The fund owned 35,300 shares of the financial services provider's stock after selling 28,475 shares during the period. Unum Group comprises about 1.7% of apricus wealth LLC's portfolio, making the stock its 25th largest holding. apricus wealth LLC's holdings in Unum Group were worth $2,876,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of UNM. Brighton Jones LLC purchased a new stake in shares of Unum Group in the fourth quarter valued at $247,000. Stratos Wealth Partners LTD. purchased a new stake in shares of Unum Group in the fourth quarter valued at $216,000. Savant Capital LLC lifted its holdings in shares of Unum Group by 1.0% in the fourth quarter. Savant Capital LLC now owns 46,344 shares of the financial services provider's stock valued at $3,385,000 after purchasing an additional 476 shares in the last quarter. Summit Trail Advisors LLC lifted its holdings in shares of Unum Group by 47.3% in the fourth quarter. Summit Trail Advisors LLC now owns 8,094 shares of the financial services provider's stock valued at $591,000 after purchasing an additional 2,600 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its holdings in shares of Unum Group by 8.0% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 312,913 shares of the financial services provider's stock valued at $22,828,000 after purchasing an additional 23,255 shares in the last quarter. Institutional investors and hedge funds own 86.57% of the company's stock.

Analyst Ratings Changes

Several analysts recently issued reports on the company. UBS Group set a $89.00 price objective on Unum Group and gave the stock a "neutral" rating in a report on Friday, May 23rd. Keefe, Bruyette & Woods cut their price objective on Unum Group from $103.00 to $102.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. Piper Sandler increased their price objective on Unum Group from $87.00 to $92.00 and gave the stock an "overweight" rating in a report on Wednesday, April 2nd. Wall Street Zen downgraded shares of Unum Group from a "buy" rating to a "hold" rating in a research report on Friday, March 7th. Finally, Morgan Stanley increased their target price on shares of Unum Group from $76.00 to $83.00 and gave the stock an "equal weight" rating in a research report on Monday, May 19th. Five research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Unum Group presently has a consensus rating of "Moderate Buy" and a consensus target price of $88.29.

Insider Buying and Selling at Unum Group

In other Unum Group news, EVP Elizabeth Claire Ahmed sold 10,000 shares of the business's stock in a transaction dated Wednesday, May 7th. The stock was sold at an average price of $80.00, for a total value of $800,000.00. Following the completion of the transaction, the executive vice president now directly owns 51,170 shares of the company's stock, valued at approximately $4,093,600. The trade was a 16.35% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.92% of the company's stock.

Unum Group Trading Down 1.5%

Shares of Unum Group stock traded down $1.21 during trading on Friday, reaching $78.04. 1,152,715 shares of the company were exchanged, compared to its average volume of 1,321,993. The company has a quick ratio of 0.28, a current ratio of 0.29 and a debt-to-equity ratio of 0.32. Unum Group has a twelve month low of $48.38 and a twelve month high of $84.48. The business has a 50-day moving average price of $79.00 and a 200-day moving average price of $77.09. The firm has a market capitalization of $13.61 billion, a price-to-earnings ratio of 8.24, a P/E/G ratio of 1.14 and a beta of 0.43.

Unum Group (NYSE:UNM - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The financial services provider reported $2.04 EPS for the quarter, missing analysts' consensus estimates of $2.19 by ($0.15). Unum Group had a return on equity of 14.91% and a net margin of 13.81%. The company had revenue of $3.09 billion for the quarter, compared to analyst estimates of $3.34 billion. During the same period last year, the firm earned $2.12 earnings per share. The firm's revenue for the quarter was down 3.4% on a year-over-year basis. Sell-side analysts anticipate that Unum Group will post 9.14 EPS for the current fiscal year.

Unum Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, May 16th. Shareholders of record on Friday, April 25th were paid a $0.42 dividend. The ex-dividend date of this dividend was Friday, April 25th. This represents a $1.68 dividend on an annualized basis and a yield of 2.15%. Unum Group's payout ratio is 19.79%.

Unum Group announced that its Board of Directors has approved a share repurchase plan on Tuesday, February 18th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the financial services provider to repurchase up to 7.4% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's board of directors believes its stock is undervalued.

Unum Group Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.